您的位置: 首页 > 农业专利 > 详情页

依帕列淨的治療用途
专利权人:
Boehringer Ingelheim International GmbH
发明人:
BROEDL, Uli Christian,CHERNEY, David,DAIBER, Andreas,VON EYNATTEN, Maximilian,JOHANSEN, Odd-Erik,KIM, Gabriel Woojai,MAYOUX, Eric Williams,MUENZEL, Thomas,PERKINS, Bruce A.,SALSALI, Afshin,SOLEYMANLOU
申请号:
HK16101968.8
公开号:
HK1213818A
申请日:
2016.02.23
申请国别(地区):
HK
年份:
2016
代理人:
摘要:
The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing oxidative stress, for example in patients with type 1 or type 2 diabetes, as well as to the use of such SGLT-2 inhibitors in treatment and/or prevention of cardiovascular diseases in patients, for example type 1 or type 2 diabetes patients. The present invention further relates to certain SGLT-2 inhibitors for treating and/or preventing a metabolic disorder and preventing, reducing the risk of or delaying the occurrence of a cardiovascular event in patients, for example patients with type 1 or type 2 diabetes.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充